Cargando…
Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial
OBJECTIVE: To analyze risk and patterns of locoregional failure (LRF) in patients of the RAPIDO trial at 5 years. BACKGROUND: Multimodality treatment improves local control in rectal cancer. Total neoadjuvant treatment (TNT) aims to improve systemic control while local control is maintained. At 3 ye...
Autores principales: | Dijkstra, Esmée A., Nilsson, Per J., Hospers, Geke A.P., Bahadoer, Renu R., Meershoek-Klein Kranenbarg, Elma, Roodvoets, Annet G.H., Putter, Hein, Berglund, Åke, Cervantes, Andrés, Crolla, Rogier M.P.H., Hendriks, Mathijs P., Capdevila, Jaume, Edhemovic, Ibrahim, Marijnen, Corrie A.M., van de Velde, Cornelis J.H., Glimelius, Bengt, van Etten, Boudewijn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481913/ https://www.ncbi.nlm.nih.gov/pubmed/36661037 http://dx.doi.org/10.1097/SLA.0000000000005799 |
Ejemplares similares
-
The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer—results from the RAPIDO trial
por: Dijkstra, E.A., et al.
Publicado: (2023) -
Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
por: Nilsson, Per J, et al.
Publicado: (2013) -
Authors’ reply—Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not
por: Zwart, W.H., et al.
Publicado: (2023) -
Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control
por: Prata, Ilaria, et al.
Publicado: (2023) -
Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint
por: Riou, Olivier, et al.
Publicado: (2023)